ARGININE INFUSION INCREASES PERIPHERAL PLASMA SOMATOSTATIN IN MAN
Corresponding Author
S. SKARE
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Dr Stile Skare, Medical Department B, Aker Hospital, Oslo 5, Norway.Search for more papers by this authorK. F. HANSSEN
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Search for more papers by this authorV. KRIZ
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Search for more papers by this authorP. A. TORJESEN
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Search for more papers by this authorCorresponding Author
S. SKARE
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Dr Stile Skare, Medical Department B, Aker Hospital, Oslo 5, Norway.Search for more papers by this authorK. F. HANSSEN
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Search for more papers by this authorV. KRIZ
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Search for more papers by this authorP. A. TORJESEN
Medical Department B and the Hormone and Isotope Laboratory, Aker Hospital, Oslo, Norway
Search for more papers by this authorSUMMARY
A somatostatin (SRIF) radioimmunoassay is described, using an antiserum raised in rabbit, reacting more with SRIF-14 than -28. Glass tubes were employed for the assay because our tracer, 125I 1-Tyr-SRIF, was adsorbed to plastic (23% non specific binding). Vycor extraction was used, and following Sephadex G-50 chromatography, the plasma extract showed two forms, coeluting with SRIF-28 and -14. Fifteen healthy subjects, eight women and seven men, 21-39 years old, received an infusion of arginine chloride (2-38 mmol/kg) for 20 min, or saline. An immediate rise in plasma SRIF from the mean basal level at 2 min was shown. Maximal value was 240±30 pmol/1 (P <: 001) after 10 min followed by a rapid descent towards the basal level after the infusion. A temporal relationship was observed between the SRIF, insulin and glucagon responses following arginine infusion, while the GH levels increased only after the SRIF levels had declined, indicating an inhibition of GH. This is further supported by the high degree of correlation (r=0-87) between SRIF- and GH increments. It is suggested that plasma SRIF measurement during arginine infusion gives an estimate of the pancreatic SRIF releasing capacity.
REFERENCE
- ARIMURA, A., SATO, H., COY, D.H. & SCHALLY A.V. (1975) Radioimmunoassay for GH-release inhibiting hormone. Proceedings of the Society for Experimental Biology and Medicine, 148, 784–789.
- BRAZEAU, P., LING, N., ESCH, E., BØHLEN, P., BENOIT, R. & GUILLEMIN R. (1981) High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regulatory Peptides, 1, 255–264.
- BRAZEAU, P., VALE, W., BURGUS, R., LING, N., BUTCHER, M., RIVIER, J. & GUILLEMIN R. (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, 179, 77–79.
- CHAYVIALLE, J.A., FORICHON, J., DESCOS, F., DANIERE, S. & RANBLIERE R.C. (1980) Effect of food on plasma immunoreactive somatostatin, vasoactive intestinal peptide and substance P in man. Regulatory Peptides, Supplement, 1, 18.
- CHIHARA, K., ARIMURA, A. & SCHALLY A.V. (1979) Immunoreactive somatostatin in rat hypophyseal portal blood. Effects of anesthetics. Endocrinology, 104, 1434–1441.
- CONLON, J.M., SRIKANT, C.B., IPP, E., SCHUSDZIARRA, V., VALE, W. & UNGER R. (1978) Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma. Journal of Clinical Investigation, 62, 1187–1193.
- DESBUQUIS, B. & AURBACH G.D. (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. Journal of Clinical Endocrinology, 33, 732–738.
- DESCOS, F., DE PARSCAU, L., OLIVE, C. & CHAYVIALLE J.A. (1981) Somatostatin-like immunoreactivity in human gastrointestinal mucosa. In 2nd International Symposium on Somatostatin.Abstract Book, Serono . p31.
- DUFAU, M.L., RYAN, D. & CATT K.J. (1974) Disulphide groups of gonadotrophin receptors are essential for specific binding of human chorionic gonadotrophin. Biochimica et Biophysica Acta, 343, 417–422.
-
EPSTEIN, S.,
BERELOWITZ, M. &
BELL N.H. (1980) Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.
Journal of Clinical Endocrinology and Metabolism, 57, 1227–1231.
10.1210/jcem-51-6-1227 Google Scholar
- FØLLING, I., & NORMAN N. (1972) Hyperglycemia, hypoglycemic attacks and production of antiinsulin antibodies without previous known immunization. Diabetes, 21, 814–926.
- HANSSEN, L.E. & TORJESEN P. (1977) Radioimmunoassay of secretin in human plasma. Scandinavian Journal of Gastroenterology, 12, 481–488.
- HARRIS, C, CONLON, J.M., SRIKANT, C.B., MCCORKLE, K., SCHUSDZIARRA V., IPP, E. & UNGER R. (1978) Measurement of somatostatin-like immunoreactivity in plasma. Clinica Chimica Acta, 87, 275–283.
- KAZUMI, T., UTSUMI, M., YOSHINO, G., ISHIHARA, K., HIROSE, Y., MAKIMURA, H. & BABA S. (1980) Somatostatin concentration responds to arginine in portal plasma. Effect of fasting, streptozotocin diabetes, and insulin administration in diabetic rats. Diabetes, 29, 71–73.
- KONIGSBERG, W. (1972) Reduction of disulphide bonds in proteins with dithiothreitol. Methods in Enzymology, 25, 185–188.
- KRONHEIM, S., BERELOWITZ, M. & PIMSTONE B.L. (1976) A radioimmunoassay for growth release-inhibiting hormone: Method and quantitative tissue distribution. Clinical Endocrinology, 5, 619–630.
- KRONHEIM, S., BERELOWITZ, M. & PIMSTONE B.L. (1978) The characterization of somatostatin-like immunoreactivity in human serum. Diabetes, 27, 523–529.
- MACHES, K., ITOH, M., GREENE, K. & GERICH J. (1981) Radioimmunoassay of human plasma somatostatin. Diabetes, 30, 728–734.
- MANDARINO, L., STENNER, D., BLANCHARD, W., NISSEN, S., GERICH, J., LING, N., BRAZEAU, P., BOHLEN, P., ESCH, F. & GUILLEMIN R. (1981) Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon. Nature, 291, 76–77.
- MARCHALONIS, J.J. (1969) An enzymatic method for the tracer iodination of immunoglobulins and other proteins. Biochemical Journal, 113, 299–305.
- MORTIMER, C.H., TUNBRIDGE, W.M.G., CARR, D., YEOMANS, L., LIND, T., COY, D.H., BLOOM, S.R., KASTIN, A., MALLISON, C.N., BESSER, G.M., SCHALLY, A.V. & HALL R. (1974) Effect of growth-hormone release-inhibiting hormone on circulating glucagon, insulin and growth hormone in normal, diabetic, acromegalic and hypopituitary patients. Lancet i, 697–701.
- NORMAN, N. & TURTER, AA.R. (1968) Radioimmunoasay studies with human growth hormone and pituitary lipid mobilizing factor. Acta Endocrinologica (Kbh.), 58, 318–338.
- PATEL, Y.C., WHEATLEY, T. NING, C. (1981) Multiple forms of immunoreactive somatostatin: Comparison of distribution in neural and nonneural tissues and portal plasma in the rat. Endocrinology, 19, 1943–1949.
- PATTON, G.S., IPP, E., DOBBS, R.E., ORCI, L., VALE, W. & UNGER R. (1976) Response of pancreatic immunoreactive somatostatin to arginine. Life Science, 19, 1957–1960.
- PENMAN, E., LOWRY, P.J., WASS, J.A.H., MARKS, V., DAWSON, A.M., BESSER, G.M. & REES L.H. (1980) Molecular forms of somatostatin in normal subjects and in patients with pancreatic somatostatinoma. Clinical Endocrinology, 12, 611–620.
- PENMAN, E., WASS, J.A.H., LUND, A., LOWRY, A., LOWRY, P.J., STEWART, J., DAWSON, A.M., BESSER, G.M. & REES L.H. (1979) Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Annals of Clinical Biochemistry, 16, 15–25.
- PRADAYROL, L., JØRNVALL, H., MUTT, V. & RIBET A. (1980) N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Letters, 109, 55–58.
- SAITO, H. & SAITO S. (1982) Plasma somatostatin in normal subjects and in various diseases: Increased levels in somatostatin producing tumors. Hormone and Metabolic Research 14, 71–76.
- SAND, T. & TORJESEN P.A. (1973) Dextran-coated charcoal used in the radioimmunoassay of human pituitary luteinizing hormone. Acta Endocrinology (Kbh), 73, 444–454.
- VON SCHENCK, H. & NILSSON O.R. (1981) Radioimmunoassay of extracted glucagon compared with 3 non-extracted assays. Clinica Chimica Acta, 109, 183–191.
- SCHENKEIN, I., LEVY, M. & UHR J.W. (1972) The use of glucose oxidase as a generator of H2O2 in the enzymatic radioiodination of components of cell surfaces. Cellular Immunology, 5, 490–493.
- SCHUSDZIARRA, V. (1980) Somatostatin-a regulatory modulator connecting nutrient entry and metabolism. Hormone and Metabolic Research, 12, 563–577.
- TANNENBAUM, G.S. (1981) Growth hormone secretary dynamics in streptozotocin diabetic. Evidence for a role of endogenous circulating somatostatin. Endocrinology, 108, 76–82.
- UTSUMI, M., MAKIMURA, H., ISHIHARA, K., MORITA, S. & BABA S. (1979) Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion. Diabetologia, 17, 319–323.
- VAITUKAITIS, J., ROBBINS, J.B., NIESCHALAG, E. & ROSS G.T. (1971) A method for producing specific antisera with small dose immunogen. Journal of Clinical Endocrinology and Metabolism, 33, 988–991.
- VINIK, A.I., LEVITT, N.S., PIMSTONE, B.L. & WAGNER L. (1981) Peripheral plasma somatostatin-like immunoreactivity responses to insulin hypoglycaemia and a mixed meal in healthy subjects and non-insulin dependent maturity onset diabetes. Journal of Clinical Endocrinology, 52, 330–337.
- WASS, J.A.H., PENMAN, E., DRYBURGH, J.R., TSIOLAKIS, D., GOLDBERG, P.L., DAWSON, A.M., BESSER, G.M. & REES L.H. (1980a) Circulating somatostatin after food and glucose in man. Clinical Endocrinology, 12, 569–574.
- WASS, J.A.H., PENMAN, E., MEDBAK, S., DAWSON, A.M., TSIOLAKIS, D., MARKS, V., BESSER, G.M. & REES L.H. (1980b) Immunoreactive somatostatin changes during insulin-induced hypoglycaemia and operative stress in man. Clinical Endocrinology, 12, 269–275.